Osaic Holdings
VNDA icon

Osaic Holdings’s Vanda Pharmaceuticals VNDA Stock Holding History

Osaic Holdings’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.12K Sell
836
-88
-10% -$575 ﹤0.01% 6929
2026
Q1 		$6.38K Buy
924
+225
+32% +$1.74K ﹤0.01% 6552
2025
Q4 		$6.17K Sell
699
-225
-24% -$1.24K ﹤0.01% 6582
2025
Q3 		$4.6K Buy
924
+404
+78% +$1.87K ﹤0.01% 6800
2025
Q2 		$2.44K Buy
520
+165
+46% +$721 ﹤0.01% 6857
2025
Q1 		$1.63K Buy
355
+34
+11% +$158 ﹤0.01% 6674
2024
Q4 		$1.54K Sell
321
-147
-31% -$706 ﹤0.01% 6710
2024
Q3 		$2.19K Sell
468
-15,871
-97% -$85.1K ﹤0.01% 6574
2024
Q2 		$92.3K Buy
16,339
+9,184
+128% +$47.4K ﹤0.01% 4204
2024
Q1 		$29.4K Sell
7,155
-7,498
-51% -$30K ﹤0.01% 5113
2023
Q4 		$61.8K Buy
14,653
+4,425
+43% +$17.9K ﹤0.01% 4768
2023
Q3 		$44.2K Buy
10,228
+3,271
+47% +$18.2K ﹤0.01% 5074
2023
Q2 		$45.8K Buy
6,957
+590
+9% +$3.78K ﹤0.01% 4996
2023
Q1 		$43.2K Buy
6,367
+1,932
+44% +$13.6K ﹤0.01% 5054
2022
Q4 		$32K Sell
4,435
-370
-8% -$3.6K ﹤0.01% 5253
2022
Q3 		$47K Sell
4,805
-730
-13% -$7.71K ﹤0.01% 4963
2022
Q2 		$60K Buy
5,535
+162
+3% +$1.68K ﹤0.01% 4821
2022
Q1 		$62K Buy
5,373
+429
+9% +$5.64K ﹤0.01% 4944
2021
Q4 		$78K Buy
4,944
+572
+13% +$9.97K ﹤0.01% 4793
2021
Q3 		$74K Buy
4,372
+30
+0.7% +$525 ﹤0.01% 4792
2021
Q2 		$93K Buy
4,342
+523
+14% +$9.36K ﹤0.01% 4541
2021
Q1 		$58K Buy
3,819
+467
+14% +$7.56K ﹤0.01% 4782
2020
Q4 		$44K Buy
3,352
+626
+23% +$7.54K ﹤0.01% 4638
2020
Q3 		$29K Sell
2,726
-1,006
-27% -$10.8K ﹤0.01% 4691
2020
Q2 		$43K Buy
3,732
+1,122
+43% +$12.7K ﹤0.01% 4292
2020
Q1 		$28K Buy
+2,610
New +$32.4K ﹤0.01% 4420

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's VNDA Position: Q2 2026 in Review

Osaic Holdings reduced its Vanda Pharmaceuticals (VNDA) stake by 9.5% in Q2 2026, selling an estimated $575 and leaving 836 shares worth $5.12K. The position accounts for ﹤0.01% of the portfolio, ranked #6929.

Osaic Holdings first reported a position in VNDA in Q1 2020 and has held it in 26 quarters since. The position peaked at $93K in Q2 2021. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Osaic Holdings held 836 shares of Vanda Pharmaceuticals worth $5.12K as of Q2 2026.
  • Osaic Holdings sold 88 Vanda Pharmaceuticals shares in Q2 2026, an estimated $575.
  • Vanda Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6929 holding.
  • Osaic Holdings first reported a position in Vanda Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Vanda Pharmaceuticals position peaked at $93K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.